liver disease
-
JNJ, BioCrossroads invest in Hoosier pharma startup at work on potential hepatitis B cure
An Indiana University spinout attracted investors from Johnson & Johnson Development Corp. and BioCrossroads with novel drugs […]
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.